Cornerstone Select Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.74M Buy
22,761
+988
+5% +$114K 1.71% 14
2025
Q4
$2.29M Buy
21,773
+957
+5% +$89.8K 1.59% 18
2025
Q3
$1.75M Buy
20,816
+3,003
+17% +$247K 1.28% 31
2025
Q2
$1.41M Buy
17,813
+757
+4% +$60.2K 1.24% 29
2025
Q1
$1.53M Buy
17,056
+2,154
+14% +$201K 1.45% 24
2024
Q4
$1.48M Buy
+14,902
New +$1.54M 1.43% 22

Other funds holding MRK

Cornerstone Select Advisors's MRK Position: Q1 2026 in Review

Cornerstone Select Advisors increased its Merck (MRK) stake by 4.5% in Q1 2026, buying an estimated $114K and bringing the position to 22,761 shares worth $2.74M. The position accounts for 1.71% of the portfolio, ranked #14.

Cornerstone Select Advisors first reported a position in MRK in Q4 2024 and has held it in 6 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Cornerstone Select Advisors held 22,761 shares of Merck worth $2.74M as of Q1 2026.
  • Cornerstone Select Advisors bought 988 Merck shares in Q1 2026, an estimated $114K.
  • Merck made up 1.71% of Cornerstone Select Advisors's portfolio in Q1 2026, its #14 holding.
  • Cornerstone Select Advisors first reported a position in Merck in Q4 2024 and has held it in 6 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Cornerstone Select Advisors's 13F filing for Q1 2026, filed 13 May 2026.